Issues related to pharmaceutical pricing. Issues related to drug shortages. Issues related to implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act.
Issues relating to drug pricing, 340B Drug pricing, device sterilization. Issues relating to safe mobility and issues relating to diabetic retinopathy. Issues relating to pandemic preparedness act. Issues related to artificial intelligence technology in healthcare; Issues around emergency preparedness and critical medical supplies.
Issues related to increasing funding for Strategic National Stockpile. Labor, Health, and Human Services appropriations.
Taxation of multinational companies. Monitor tax reform proposal relating to corporate tax policies. Issues related to implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act.
None.